What is the WIPO Sequence tool and how does it help with Sequence Listing XML?
The WIPO Sequence tool is a software application designed to assist patent applicants in generating a compliant “Sequence Listing XML”. According to MPEP § 2413.01(b): “Use of the WIPO Sequence tool will enable a user to generate a ‘Sequence Listing XML’ that conforms to the DTD in Annex II.” This tool helps ensure that the…
Read MoreWhen did the requirement for a valid Sequence Listing XML become effective?
The requirement for a valid Sequence Listing XML became effective for patent applications filed on or after July 1, 2022. This is clearly stated in the editor’s note in MPEP § 2413.01(b): “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid…
Read MoreWhat is a “Sequence Listing XML” and why must it be valid according to the DTD?
A “Sequence Listing XML” is a standardized format for presenting nucleotide and/or amino acid sequences in patent applications. It must be valid according to the Document Type Definition (DTD) as specified in MPEP § 2413.01(b) and 37 CFR 1.833(b)(1). The MPEP states: “The ‘Sequence Listing XML’ presented in accordance with paragraph (a) of this section…
Read MoreWhat are the consequences of submitting an invalid Sequence Listing XML?
While the MPEP section doesn’t explicitly state the consequences, submitting an invalid Sequence Listing XML can lead to significant issues in the patent application process. Based on the requirements outlined in MPEP § 2413.01(b) and 37 CFR 1.833(b)(1), an invalid submission may result in: Rejection or objection to the application Delays in examination Potential loss…
Read More